​

Funding Round

Venture Round - Orphazyme

Venture Round - Orphazyme

Investment Firm

Overview

Orphazyme develops innovative new therapies for the treatment of a family of serious genetic disorders called lysosomal storage diseases.

Announced Date

Nov 16, 2017

Funding Type

Series Unknown

Highlights

Location

Europe

Social

Investor Lead

Kurma Partners

Kurma Partners

Kurma Partners is a convertible_note and debt and early_stage_venture and late_stage_venture and post_ipo and seed and venture firm.

Participant Investors

6

Investor Name
Participant InvestorNovo Holdings
Participant InvestorAescap Venture
Participant InvestorEQT Life Sciences
Participant InvestorIdinvest Partners
Participant InvestorSunstone Life Science Ventures

Round Details and Background

Orphazyme raised $94225840 on 2017-11-16 in Venture Round

Orphazyme develops innovative new therapies for the treatment of a family of serious genetic disorders called lysosomal storage diseases.

Company Funding History

7

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Mar 08, 2017
Venture Round - Orphazyme
7-14.8M
Jan 09, 2015
Series B - Orphazyme
4-24.0M
Sep 07, 2011
Series A - Orphazyme
3-20.0M
Feb 14, 2011
Seed Round - Orphazyme
2-undefined

Recent Activity

There is no recent news or activity for this profile.